Related Experiment Video
Updated: Jan 24, 2026

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics
Published on: May 3, 2024
Translating spatial transcriptomic signatures in adenosquamous carcinoma into bulk prognostic biomarkers in lung
Keiichi Hatakeyama1, Takuya Kawata2, Koji Muramatsu2
1Cancer Multiomics Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan. k.hatakeyama@scchr.jp.
Abstract:
Spatial transcriptomics enables the detection of rare or transitional tumor states not captured by bulk transcriptomics or immunohistochemistry (IHC). However, translating these spatially defined states into clinically relevant biomarkers is challenging, because signals from minor populations are underrepresented or masked in bulk data. Lung adenosquamous carcinoma (ASC), containing intermixed adenocarcinoma and squamous components, provides a model to study lineage transitions and poorly differentiated states unresolved in bulk datasets. Spatial transcriptomic profiling of ASC was integrated with TTF-1 and p40 IHC to detect tumor populations lacking these markers. Gene signatures from IHC-negative populations were projected onto bulk lung adenocarcinoma datasets to assess prognostic relevance. We implemented a color-space uniform manifold approximation and projection visualization (RGB-UMAP) to enhance the spatial mapping of rare transcriptional states that were unresolved by conventional clustering. We identified a TTF-1/p40-negative tumor cell population with a hybrid adenocarcinoma-squamous expression pattern and upregulation of SLC2A1 (GLUT1). RGB-UMAP clarified these states and distinguished them from normal epithelial cells. In bulk lung adenocarcinoma cohorts, high SLC2A1 expression stratified patients with poorer survival. This study demonstrates a bottom-up biomarker discovery strategy translating spatially defined, IHC-negative tumor cell populations in ASC into stratifiers for lung adenocarcinoma.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Termination of Translation
Bulk Modulus
Improving Translational Accuracy

